Advancing Immunotherapy with Novel Antigen Discovery

AilseBio is developing innovative immunotherapies powered by its proprietary TiNADiscovery platform.

A groundbreaking class of Therapy Induced Novel Antigens with unique features, representing a new frontier for Immunotherapy